This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor

NCT00033202 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Malignancies

Interventions

DRUG: Gimatecan® (ST-1481)

Sponsor

Sigma-Tau Research, Inc.

Collaborators

[object Object]
[object Object]